Pautas E - Search Results

1

Elderly medical patients treated with prophylactic dosages of enoxaparin: influence of renal function on anti-Xa activity level.

Mahe I, Gouin-Thibault I, Drouet L, Simoneau G, Di Castillo H, Siguret V, Bergmann JF, Pautas E. Mahe I, et al. Among authors: pautas e. Drugs Aging. 2007;24(1):63-71. doi: 10.2165/00002512-200724010-00005. Drugs Aging. 2007. PMID: 17233548 Clinical Trial.

2

[A geriatric perspective on the sixth IPCC synthesis report].

Gay P, Pautas É. Gay P, et al. Among authors: pautas e. Soins Gerontol. 2023 Nov-Dec;28(164):37-40. doi: 10.1016/j.sger.2023.09.009. Epub 2023 Oct 15. Soins Gerontol. 2023. PMID: 37977763 Review. French.

3

Neuro-Psychological Outcome of ICU-Admitted COVID-19 Patients Presenting With CNS Complications.

Pelle J, Nedelec T, Marois C; Coco Neurosciences study group. Pelle J, et al. Crit Care Med. 2023 Apr 1;51(4):e101-e103. doi: 10.1097/CCM.0000000000005738. Epub 2023 Mar 18. Crit Care Med. 2023. PMID: 36928023 No abstract available.

4

Elderly patients treated with tinzaparin (Innohep) administered once daily (175 anti-Xa IU/kg): anti-Xa and anti-IIa activities over 10 days.

Siguret V, Pautas E, Février M, Wipff C, Durand-Gasselin B, Laurent M, Andreux JP, d'Urso M, Gaussem P. Siguret V, et al. Among authors: pautas e. Thromb Haemost. 2000 Nov;84(5):800-4. Thromb Haemost. 2000. PMID: 11127859

5

[Monitoring of tinzaparin in a ten day treatment dose in elderly patients].

Pautas E, Siguret V, d'Urso M, Laurent M, Gaussem P, Février M, Durand-Gasselin B. Pautas E, et al. Rev Med Interne. 2001 Feb;22(2):120-6. doi: 10.1016/s0248-8663(00)00301-5. Rev Med Interne. 2001. PMID: 11234669 Clinical Trial. French.

6

Safety profile of tinzaparin administered once daily at a standard curative dose in two hundred very elderly patients.

Pautas E, Gouin I, Bellot O, Andreux JP, Siguret V. Pautas E, et al. Drug Saf. 2002;25(10):725-33. doi: 10.2165/00002018-200225100-00005. Drug Saf. 2002. PMID: 12167068 Clinical Trial.

7

[Oral anticoagulants in the elderly].

Debray M, Pautas E, Couturier P, Franco A, Siguret V. Debray M, et al. Among authors: pautas e. Rev Med Interne. 2003 Feb;24(2):107-17. doi: 10.1016/s0248-8663(02)00020-6. Rev Med Interne. 2003. PMID: 12650892 Review. French.

8

[Excess antivitamin K in elderly hospitalised patients aged over 70. A one-year prospective survey].

Siguret V, Esquirol C, Debray M, Gouin I, Andreux JP, Pautas E. Siguret V, et al. Among authors: pautas e. Presse Med. 2003 Jun 14;32(21):972-7. Presse Med. 2003. PMID: 12876525 French.

9

Heparin-releasable TFPI is not depleted after repeated injections of tinzaparin at therapeutic dose for up to 30 days.

Gouin-Thibault I, Pautas E, Depasse F, Andreux JP, Siguret V. Gouin-Thibault I, et al. Among authors: pautas e. J Thromb Haemost. 2003 Dec;1(12):2694-5. doi: 10.1111/j.1538-7836.2003.0543k.x. J Thromb Haemost. 2003. PMID: 14675115 Free article. No abstract available.

10

[Cytochrome P450 2C9 polymorphisms (CYP2C9) and warfarin maintenance dose in elderly patients].

Siguret V, Gouin I, Golmard JL, Geoffroy S, Andreux JP, Pautas E. Siguret V, et al. Among authors: pautas e. Rev Med Interne. 2004 Apr;25(4):271-4. doi: 10.1016/j.revmed.2003.11.006. Rev Med Interne. 2004. PMID: 15050794 Clinical Trial. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters